© The International League Against Epilepsy
Edited By: Astrid Nehlig, PhD, Michael Sperling, MD. and Gary W. Mathern, MD.
Impact Factor: 4.706
ISI Journal Citation Reports © Ranking: 2015: 25/192 (Clinical Neurology)
Online ISSN: 1528-1167
Controversy in Epilepsy
Read varying viewpoints on controversial issues in the field of epilepsy
Addressing the important issues of the degree to which epileptic activity contributes to poorer developmental and cognitive outcomes above and beyond that which would be expected from the underlying etiology, which might influence treatment considerations.
Two sides of the argument are presented regarding the place of dietary treatments when standard anticonvulsant medications fail and surgery is not an option.
Sudden unexpected death from epilepsy (SUDEP) has attracted considerable attention in the past several years, and there is increasing pressure from the epilepsy community to encourage medical professionals to tell their patients about it.
The Asia versus Africa controversy stems from a sentence interpreted out of context, when addressing the cultural context of epilepsy in the African continent. Other communities in Asia and Latin America also have epilepsy embedded in their beliefs in similar ways.
Epilepsy: Asia versus Africa
Despite hundreds, if not thousands, of years of careful observation and documentation, as clinicians we still struggle to find accurate terminology for describing seizures and classifying types of epilepsy
Proposal: Different types of alteration and loss of consciousness in epilepsy
An important unresolved issue in the epidemiology of epilepsy is the unexplained difference between the accumulative incidence (adding up the number of new cases per year) and lifetime prevalence (number of people with epilepsy within a population). The possible reasons for this discrepancy are the subject of this month's Controversy in Epilepsy series
An unknown quantity—The worldwide prevalence of epilepsy
In this edition of Epilepsia, we present a series of articles on the potential use of CBD and medical marijuana for epilepsy. **See survey results from this Controversy series**
Addressing the need for the Wada test (intracarotid amobarbital procedure, IAP) and extraoperative language and motor mapping in patients who are undergoing epilepsy surgery. The question: Can some or all of these tests be abandoned in favor of less-invasive and sometimes lower cost techniques?